These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8043483)

  • 41. [Hepatitis C epidemiology in the central area of Portugal. Prevalence of anti-HCV in the population of the district of Coimbra].
    Santos A; Carvalho A; Bento D; Sá R; Tomaz J; Rodrigues V; Pais L; Porto A
    Acta Med Port; 1993 Dec; 6(12):567-72. PubMed ID: 8165925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The presence of hepatitis C virus antibodies in various risk groups].
    Roşiu N; Pop O; Claici C; Coflec D; Novac VP; Stein R; Nicoară E; Bodea A; Boieriu E; Niculescu V
    Rev Roum Virol; 1994; 45(1-2):97-101. PubMed ID: 7538780
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad.
    Al-Kubaisy WA; Al-Naib KT; Habib MA
    East Mediterr Health J; 2006; 12(3-4):264-9. PubMed ID: 17037693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Seroprevalence of Hepatitis C Virus (HCV) in patients of the Regional Viral Reference Laboratory (Maracaibo, Venezuela)].
    Cuadra-Sánchez C; Moronta-Piñango R; Córdova-Villanueva E; Mindiola-Morles R; Araujo-Soto M; Callejas-Monsalve D; Porto-Espinoza L
    Rev Gastroenterol Peru; 2005; 25(3):248-53. PubMed ID: 16237468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
    Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
    Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan.
    Akhtar S; Younus M; Adil S; Jafri SH; Hassan F
    J Viral Hepat; 2004 Nov; 11(6):527-35. PubMed ID: 15500553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
    Akcam FZ; Uskun E; Avsar K; Songur Y
    Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A seroepidemiological investigation on HCV infection among population in Tianjin area].
    Lu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):147-50. PubMed ID: 8221836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The prevalence of anti-HCV antibodies in a population of Sicilian hemodialysis patients].
    Soresi M; Montalto G; Galione A; Carroccio A; Bonfissuto G; Di Martino D; Annaloro R; Notarbartolo A
    Recenti Prog Med; 1994 Sep; 85(9):415-8. PubMed ID: 7938871
    [No Abstract]   [Full Text] [Related]  

  • 51. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.
    Jeannel D; Fretz C; Traore Y; Kohdjo N; Bigot A; Pê Gamy E; Jourdan G; Kourouma K; Maertens G; Fumoux F; Fournel JJ; Stuyver L
    J Med Virol; 1998 Jun; 55(2):92-7. PubMed ID: 9598927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria.
    Halim NK; Ajayi OI
    East Afr Med J; 2000 Aug; 77(8):410-2. PubMed ID: 12862062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
    Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
    Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody to hepatitis-C virus in multi-transfused thalassaemics--Indian experience.
    Agarwal MB; Malkan GH; Bhave AA; Vishwanathan C; Billa V; Dube SR; Bajan K; Rajadhyaksha GC; Shah SH
    J Assoc Physicians India; 1993 Apr; 41(4):195-7. PubMed ID: 8270554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
    Bagga PK; Singh SP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevalence of antibodies against hepatitis C virus in a sample of homosexual males].
    Morales MA; Pineda JA; Leal M; Pino R; Torronteras R; Sánchez-Quijano A; Lissen E
    Med Clin (Barc); 1993 Jan; 100(2):50-2. PubMed ID: 8429709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.
    Araj GF; Kfoury-Baz EE; Barada KA; Nassif RE; Alami SY
    J Med Liban; 1995; 43(1):11-6. PubMed ID: 8676356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.